Inclusion of ABI may better identify vascular disease

Inclusion of ABI may better identify vascular disease
Inclusion of the ankle/brachial index may better identify vascular disease in patients with non-valvular atrial fibrillation, according to a study published online Aug. 14 in the Journal of the American College of Cardiology.

(HealthDay)—Inclusion of the ankle/brachial index (ABI) may better identify vascular disease in patients with non-valvular atrial fibrillation (NVAF), according to a study published online Aug. 14 in the Journal of the American College of Cardiology.

Francesco Violi, M.D., from the Sapienza University Of Rome, and colleagues enrolled consecutive adult patients with NVAF referred to internal medicine wards (October 2010 through October 2012) who had ABI measurements. Patients with acquired or congenital valvular AF, active cancer, disease with life expectancy less than three years, hyperthyroidism, and pregnancy were excluded.

The researchers found that, of the 2,027 NVAF patients included in the study, 83 percent had hypertension, 23 percent had diabetes mellitus, 39 percent had , 29 percent had , and 15 percent smoked. Additionally, at least one atherosclerotic risk factor was detected in 90 percent of patients. Despite being at high risk for stroke, 16 percent were untreated with any antithrombotic drug, 19 percent were treated with , 61 percent were treated with oral anticoagulants, and 4 percent were treated with both antiplatelet drugs and oral anticoagulants. Just over one-fifth (21 percent) had ABI ?0.90, indicating that NVAF is often associated with systemic atherosclerosis. Inclusion of ABI ?0.90 in the CHA2DS2-VASc score allowed for better identification of the risk profile, with an up-grading of the in each score category.

"This study provides the first evidence that one-fifth of NVAF patients had an ABI ?0.90, indicating that it may represent a simple and cheap method to better define the prevalence of vascular disease in NVAF," the authors write.

One author disclosed financial ties to the pharmaceutical industry.

More information: Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

GPs undertreat women with AF

Sep 01, 2013

General practitioners (GPs) undertreat women with atrial fibrillation (AF), according to research presented at ESC Congress 2013 today by Dr Pierre Sabouret from France. The analysis of more than 15,000 patients showed that ...

Recommended for you

Pay-for-performance not found to impact access to CABG

15 hours ago

(HealthDay)—For patients with acute myocardial infarction (AMI), treatment at pay-for-performance (P4P) hospitals is not associated with a change in the rate of coronary artery bypass graft (CABG) surgery, ...

A prescription for better stroke care

22 hours ago

Stroke patients are 70 per cent more likely to continue taking their stroke prevention medications one year later if they have a prescription in hand when discharged – according to researchers at St. Michael's ...

User comments